The Aortix CRS Pilot Study

NACompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

February 5, 2021

Primary Completion Date

October 7, 2022

Study Completion Date

March 9, 2023

Conditions
Heart Failure; With DecompensationCardiorenal SyndromeCardio-Renal SyndromeHeart FailureHeart Failure,CongestiveHeart Failure, SystolicHeart Failure, Diastolic
Interventions
DEVICE

Aortix System

Aortix is a circulatory support device for chronic heart failure patients on medical management who have been hospitalized for acute decompensated heart failure (ADHF) with worsening renal function.

Trial Locations (19)

10032

Columbia University/New York Presbyterian, New York

20042

Inova Health Care Services, Falls Church

23502

Sentara Hospital, Norfolk

32610

University of Florida, Gainesville

33331

Cleveland Clinic Florida, Weston

33620

University of South Florida, Tampa

45219

Christ Hospital, Cincinnati

48109

University of Michigan, Ann Arbor

48202

Henry Ford Health System, Detroit

60637

University of Chicago, Chicago

77030

Houston Methodist, Houston

80045

University of Colorado, Denver

90033

University of Southern California, Los Angeles

94143

University of California, San Francisco, San Francisco

Unknown

St. Vincent's Hospital, Sydney

Prince Charles Hospital, Brisbane

Royal Adelaide Hospital, Adelaide

The Alfred Hospital, Melbourne

Western Health, Footscray Hospital, Melbourne

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Procyrion Australia Pty Ltd

INDUSTRY

lead

Procyrion

INDUSTRY

NCT04145635 - The Aortix CRS Pilot Study | Biotech Hunter | Biotech Hunter